Grade: GMP product Tested for sterility and bacterial endotoxins Description: PSMA-BCH, also known as NOTA-PSMA, is a PSMA-NOTA-conjugated precursor. ⁶⁸Ga-PSMA-BCH can be used for prostate cancer imaging. Al¹⁸F-PSMA-BCH is a novel ¹⁸F PET radiotracer for prostate cancer. ⁶⁴Cu-PSMA-BCH is a new radiotracer for delayed PET imaging of prostate cancer. It is PSMA-specific, shows high in vivo stability, and has lower liver uptake compared to ⁶⁴Cu-PSMA-617. Biodistribution studies in mice and PCa patients revealed a similar profile to other PSMA ligands. The compound was found to be safe and exhibited moderate effective dosimetry. Synonyms: NOTA-PSMA Molar weight: 941.03 g/mol (net substance) Molecular formula: C₄₅H₆₄N₈O₁₄ (net substance) CAS №: 1703768-74-4 Retest date: Not less than 18 months from the manufacturing date Packaging: 2R/4ml or 8R/10ml Type I glass vials with bromobutyl rubber stoppers Storage conditions: –20 ±5 °C Transportation at 2–8 °C (less than 1 month) Available quantities: 0.1 mg; 1.0 mg; custom quantity upon request